Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q4 2018 · 10-K
Revenue$67.32M$67.32M+6.8% vs Q4 2017 Net Income$10.18M$10.18M+35.7% vs Q4 2017 EPS Diluted$0.50$0.50+35.1% vs Q4 2017 Gross Profit$24,919,000+12.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,234,000−85.6% Free Cash Flowderived$2,095,000−85.9% Margins · derivedGross margin37.0%+1.9 pt vs Q4 2017
Operating margin20.8%+2.2 pt vs Q4 2017
Net margin15.1%+3.2 pt vs Q4 2017
ended Mar 31, 2018 · filed May 29, 2018 · 59 d after period end